Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. More Details
Flawless balance sheet, undervalued and pays a dividend.
Share Price & News
How has Excelsior Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4104 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: 4104's weekly volatility (2%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 4104 underperformed the TW Healthcare industry which returned 15.2% over the past year.
Return vs Market: 4104 underperformed the TW Market which returned 44.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Excelsior Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StThere's Been No Shortage Of Growth Recently For Excelsior Medical's (TPE:4104) Returns On Capital
2 months ago | Simply Wall StA Look At The Intrinsic Value Of Excelsior Medical Co., Ltd. (TPE:4104)
2 months ago | Simply Wall StExcelsior Medical Co., Ltd.'s (TPE:4104) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Is Excelsior Medical undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 4104 (NT$57.6) is trading below our estimate of fair value (NT$329.33)
Significantly Below Fair Value: 4104 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 4104 is good value based on its PE Ratio (14.4x) compared to the TW Healthcare industry average (17.3x).
PE vs Market: 4104 is good value based on its PE Ratio (14.4x) compared to the TW market (17.2x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 4104's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 4104 is good value based on its PB Ratio (1.1x) compared to the TW Healthcare industry average (1.9x).
How is Excelsior Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Excelsior Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Excelsior Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4104 has high quality earnings.
Growing Profit Margin: 4104's current net profit margins (8.6%) are higher than last year (7.9%).
Past Earnings Growth Analysis
Earnings Trend: 4104's earnings have grown by 8.4% per year over the past 5 years.
Accelerating Growth: 4104's earnings growth over the past year (8%) is below its 5-year average (8.4% per year).
Earnings vs Industry: 4104 earnings growth over the past year (8%) exceeded the Healthcare industry -2.6%.
Return on Equity
High ROE: 4104's Return on Equity (7.3%) is considered low.
How is Excelsior Medical's financial position?
Financial Position Analysis
Short Term Liabilities: 4104's short term assets (NT$8.7B) exceed its short term liabilities (NT$4.8B).
Long Term Liabilities: 4104's short term assets (NT$8.7B) exceed its long term liabilities (NT$384.8M).
Debt to Equity History and Analysis
Debt Level: 4104's debt to equity ratio (4%) is considered satisfactory.
Reducing Debt: 4104's debt to equity ratio has reduced from 22% to 4% over the past 5 years.
Debt Coverage: 4104's debt is well covered by operating cash flow (345.4%).
Interest Coverage: 4104 earns more interest than it pays, so coverage of interest payments is not a concern.
What is Excelsior Medical current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4104's dividend (6.08%) is higher than the bottom 25% of dividend payers in the TW market (2.06%).
High Dividend: 4104's dividend (6.08%) is in the top 25% of dividend payers in the TW market (5.01%)
Stability and Growth of Payments
Stable Dividend: 4104's dividend payments have been volatile in the past 10 years.
Growing Dividend: 4104's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (87.4%), 4104's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Sheng Gao serves as the General Manager of Excelsior Medical Co.,Ltd.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Excelsior Medical Co., Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Excelsior Medical Co., Ltd.
- Ticker: 4104
- Exchange: TWSE
- Founded: 1988
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: NT$8.130b
- Shares outstanding: 141.15m
- Website: https://www.excelsiormedical.com.tw
- Excelsior Medical Co., Ltd.
- No. 880, Zhongzheng Road
- 17th Floor
- New Taipei City
Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medica...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/09 23:57|
|End of Day Share Price||2021/06/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.